GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Share Price & Technical Analysis
GLAXO · ₹2,455 (-2.05%)
Healthcare / Drug Manufacturers - General
₹2,455
-2.05%
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granul…
Price chart
Seasonality
Jul has 1 positive and 4 negative years (last 5 years shown)
-1% return in Jul, -2% avg return in past 3 year Jul month.
1% return in 2026, 26% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | 7% | -9% | 1% | -5% | 11% | -1% | – | – | – | – | – | 1% |
| 25 | -12% | 27% | 16% | 3% | 12% | 3% | -7% | -12% | -5% | -2% | -3% | -3% | 19% |
| 24 | 18% | -3% | -10% | 7% | 24% | 1% | 3% | 0% | 0% | -1% | -10% | -8% | 20% |
| 23 | -4% | 6% | -1% | -7% | 5% | 9% | -2% | 2% | 9% | -8% | 16% | 14% | 40% |
| 22 | -11% | -4% | 9% | -4% | -3% | -2% | -7% | 3% | -2% | -3% | -3% | -2% | -30% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Uptrend
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix. It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for the treatment of chronic obstructive pulmonary disease; and Seretide. In addition, the company offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections, and skin infections; Ceftum, an anti-infective medicine; Calpol and Calpol T for pain management; Eltroxin for the treatment of hypothyroidism; Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate for dermatology indications; and CobadexCZS and CCM, which are mineral, vitamins, and nutrition products. Further, it provides oncology medicines, including Jemperli and Zejula. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. The company was incorporated in 1924 and is headquartered in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹424.58B
P/E ratio
41.02
52W high
₹3,220
52W low
₹2,088
Volume
55,499
Beta
0.04
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹3,165
Coral Laboratories Ltd.
₹593.3
Frequently asked questions
- What is GLAXOSMITHKLINE PHARMACEUTICALS LIMITED share price today?
- GLAXOSMITHKLINE PHARMACEUTICALS LIMITED (GLAXO) last traded around ₹2,455 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GLAXO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GLAXO. Download the app for real-time alerts.
- How can I analyze GLAXOSMITHKLINE PHARMACEUTICALS LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.